Mountain Pacific Venture Fund Invests in Decoy Biosystems

Salt Lake City, UT, Thursday, October 18, 2018 –Mountain Pacific Venture Fund announced today its investment in Decoy Biosystems, a San Diego, California-based cancer immunotherapy company that was recently accepted into the Johnson & Johnson Innovation, JLABS (JLABS) life science incubator. The investment was part of a $6.0 million seed round syndicated with TY BIO […]

Read More

BioUtah Announces Jeffrey Shuren, MD, JD, Director of the Center for Devices and Radiological Health as the Luncheon Keynote Speaker for the 9th Annual Utah Life Sciences Summit

Dr. Shuren will take the stage as the luncheon keynote at the 2018 BioUtah Utah Life Sciences Summit, speaking to the state’s premier gathering of industry leaders, innovators, government officials, educators, and investors September 14, 2018 10:00 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–BioUtah, Utah’s only trade association dedicated solely to the life sciences community, […]

Read More

BioUtah Announces Registration and Headline Speakers for the 9th Annual Utah Life Sciences Summit (ULSS)

Registration opens today for the 2018 BioUtah ULSS, offering early bird discounts. Preliminary speaker line-up includes notable business leaders, policy makers and members of the investor community Salt Lake City, UT – September 5, 2018 – BioUtah, Utah’s one and only association dedicated to the life sciences community, today announced that registration is open for […]

Read More

ULSS Early Bird Registration Opens September 5th

On November 1, BioUtah will be holding its 9th annual Utah Life Sciences Summit (ULSS). This is the premier conference for companies on the cutting edge of medical innovation, and provides a unique opportunity to connect with national leaders in the life sciences industry. Please join us for keynote speakers, panels, and networking opportunites that […]

Read More

BioUtah Statement on U.S. House of Representatives Passage of  Legislation to Permanently Repeal the Medical Device Tax

FOR IMMEDIATE RELEASE July 25, 2018 BioUtah Statement on U.S. House of Representatives Passage of  Legislation to Permanently Repeal the Medical Device Tax Salt Lake City – BioUtah issued the following statement from President and CEO, Kelly Slone, regarding passage of the Protect Medical Innovation Act of 2017 (H.R. 184) in the U.S. House of […]

Read More

Biomerics Acquires FutureMatrix Interventional

Biomerics LLC, a medical device contract manufacturer headquartered in Salt Lake City, UT is pleased to announce the acquisition of FutureMatrix Interventional, Inc. FMI, located in Athens, TX specializes in the design and manufacture of interventional catheters for the cardiovascular and urology markets. […]

Read More

Reimbursement Trends Webinar

Joins us for a timely update from Brian Carey, Partner, Foley Hoag, on reimbursement trends for precision medicine and Kim Linthicum, Vice President of Government Affairs, Myriad, on proposed legislation that would create a new regulatory pathway for diagnostics. […]

Read More